Why You Can’t Build a Medtech Start-Up Without Publicity
Interview with Peter Vranes, CEO of Nutromics
Transitioning from skincare to medical devices sounds like a leap from the superficial to the super serious.
But Peter Vranes, co-CEO and co-founder of wearable smart patch Nutromics, says that building skincare brand Lapureté in his native Australia gave him insights into some of the most important aspects of founding a medtech company.
As an anti-aging line, Lapureté sat at a crossroads between cosmetics and therapeutics. This meant Peter and his team had to pay closer attention to regulations than other beauty brands.
That experience taught him a lesson: planning early can prevent disasters down the line. It’s an insight that has influenced how Peter approaches various aspects of Nutromics, including the fundraising part.
Planning ahead is also baked into the company’s mission. Nutromics is working on a digitally connected wearable patch that can track molecular targets. It will be able to send that information straight to medical professionals, so they can see if a patient is at risk for a particular disease.
The aim is to catch warning signs of conditions like diabetes, kidney failure and cardiovascular disease so they can be treated before they advance. Nutromics’ goal is that this information will motivate wearers to moderate their lifestyle in ways that can prevent these illnesses.
In this episode of Medsider, Peter explains how and why he learned to embrace publicity as a necessary part of doing business, why getting your device approved goes beyond government regulatory bodies, and why he never stops raising money.
You May Like These Articles
Medsider Premium
Become a premium member and unlock access to exclusive Medsider benefits.
